Run-tao Li
发表
Jiaolin Bao,
Yingbo Li,
Mei-wan Chen,
2013,
Cancer letters.
W. Lu,
Run-tao Li,
Xiao Zhu,
2016,
Acta Pharmacologica Sinica.
Run-tao Li,
Junyu Li,
S. Mollah,
2014
.
Z. Ge,
Run-tao Li,
T. Cheng,
2012,
Molecular Diversity.
W. Guo,
Bo Xu,
Min Li,
2008,
Anti-cancer drugs.
Yuyang Jiang,
Run-tao Li,
Sheng-li Cao,
2005,
Bioorganic & medicinal chemistry letters.
Baoxue Yang,
Run-tao Li,
Yue Xu,
2019,
Acta Pharmacologica Sinica.
W. Lu,
Run-tao Li,
T. Zhou,
2013,
Acta Pharmacologica Sinica.
Z. Ge,
Run-tao Li,
T. Cheng,
2006,
Bioorganic & medicinal chemistry letters.
Hong-Mei Zhang,
Run-tao Li,
T. Cheng,
2003,
Bioorganic & medicinal chemistry letters.
Yingbo Li,
Zhong-Qing Wang,
Z. Ge,
2015,
European journal of medicinal chemistry.
Z. Ge,
Run-tao Li,
T. Cheng,
2012,
Molecular Diversity.
Yingbo Li,
P. Liu,
Demin Zhou,
2016,
European journal of medicinal chemistry.
P. Liu,
Z. Ge,
Run-tao Li,
2014,
Molecular Diversity.
Xin Wang,
Xia Yuan,
Xing-Yu Wu,
2017,
European journal of medicinal chemistry.
Run-tao Li,
Xian‐Ying Shi,
Junfa Wei,
2009,
Organic letters.
Run-tao Li,
Xian‐Ying Shi,
Junfa Wei,
2009,
The Journal of organic chemistry.
Run-tao Li,
Qi Sun,
Jia Ye,
2007,
Pharmacology Biochemistry and Behavior.
Z. Ge,
Run-tao Li,
Xin Wang,
2011,
Bioorganic & medicinal chemistry letters.
Run-tao Li,
T. Cheng,
Qi Sun,
2007,
Bioorganic & medicinal chemistry letters.
Run-tao Li,
Xin Wang,
Jia Ye,
2007,
Bioorganic & medicinal chemistry letters.
Run-tao Li,
T. Cheng,
Xin Wang,
2003,
Bioorganic & medicinal chemistry letters.
Hong-Mei Zhang,
Run-tao Li,
T. Cheng,
2003,
Bioorganic & medicinal chemistry letters.
Run-tao Li,
Junchao Cai,
X. Tang,
1999,
Archiv der Pharmazie.
Tingyun Yang,
Qiang Zhang,
Run-tao Li,
2012,
Journal of controlled release : official journal of the Controlled Release Society.
Hong-Mei Zhang,
Run-tao Li,
T. Cheng,
2003,
Archiv der Pharmazie.
Run-tao Li,
Xian‐Ying Shi,
Junfa Wei,
2009
.
W. Guo,
J. Cui,
Z. Ge,
2006,
Bioorganic & medicinal chemistry letters.
Run-tao Li,
Qi Sun,
Jia Ye,
2020,
Inflammation.
Z. Ge,
Run-tao Li,
Xin A. Zhang,
2011,
Bioorganic & medicinal chemistry letters.
Fu-xiang Ran,
J. Cui,
Z. Ge,
2016
.
Jianfeng Pei,
Yong Zhu,
Zhen-ming Liu,
2006,
Bioorganic & medicinal chemistry.
Fu-xiang Ran,
J. Cui,
Z. Ge,
2016,
Journal of Cancer.
W. Guo,
Fu-xiang Ran,
Bo Xu,
2015,
Journal of Cancer.
Z. Ge,
Run-tao Li,
Runtao Li,
2017,
Synthesis.
Run-tao Li,
W. Lu,
T. Zhou,
2012
.
Run-tao Li,
Shengyu Cao,
Zhen-Zhong Liu,
1994
.
Z. Ge,
Run-tao Li,
T. Cheng,
2014,
Molecular diversity.
SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells
J. Cui,
Run-tao Li,
Wei Guo,
2008,
Anti-cancer drugs.
W. Guo,
Bo Xu,
Min Li,
2008,
Anti-cancer drugs.
J. Cui,
Z. Ge,
Run-tao Li,
2001,
Archiv der Pharmazie.
Run-tao Li,
M. Cai,
P.‐Y. Ding,
1998
.
SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells
J. Cui,
Run-tao Li,
Wei Guo,
2008,
Anti-cancer drugs.